Memorial Hospital Research Laboratories
Physician-scientist Cristina Antonescu studies the molecular pathogenesis of soft tissue sarcomas and gastrointestinal stromal tumors.
Human Oncology & Pathogenesis Program
Physician-scientist Michael Berger focuses on massively parallel sequencing of tumor DNA for biomarker discovery and clinical diagnostics.
Human Oncology & Pathogenesis Program
Physician-scientist Cameron Brennan focuses on genomic analysis of human and mouse gliomas and medulloblastomas.
Memorial Hospital Research Laboratories
Physician-scientist Brett Carver focuses on the identification of molecular pathways involved in prostate cancer initiation and progression.
Human Oncology & Pathogenesis Program
Physician-scientist Timothy Chan focuses on the identification and characterization of tumor suppressors in glioblastoma and breast cancer.
Human Oncology & Pathogenesis Program
Physician-scientist Emily Cheng focuses on the molecular mechanisms of cell death and their implications in tumorigenesis and cancer therapy.
Human Oncology & Pathogenesis Program
Physician-scientist Ping Chi studies genetic and epigenetic mechanisms of transcriptional regulation by oncogenic transcription factors in GIST and other solid tumors.
Human Oncology & Pathogenesis Program
Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.
Cell Biology Program
Cell biologist Filippo Giancotti investigates signaling by cell adhesion receptors, neoplastic transformation, and metastatic dissemination.
Memorial Hospital Research Laboratories
Physician-scientist Cyrus Hedvat focuses on the identification of clinically relevant genomic alterations in acute myeloid leukemia.
Cancer Biology & Genetics Program
Physician-scientist Eric Holland focuses on the molecular mechanisms underlying the pathogenesis of CNS tumors and modeling of these cancers in the mouse.
Human Oncology & Pathogenesis Program
Physician-scientist James Hsieh focuses on the development of novel therapeutics targeting cancer cell proliferation and establishment of a translational kidney cancer program.
Memorial Hospital Research Laboratories
Physician-scientist Katharine Hsu studies the biology of human natural killer cells and how they contribute to disease processes.
Human Oncology & Pathogenesis Program
Physician-scientist Jason Huse focuses on the molecular pathogenesis of brain tumors, particularly high-grade gliomas.
Cancer Biology & Genetics Program
Cancer biologist Johanna Joyce investigates the signaling pathways between cancer cells and their microenvironment in tumor progression, metastasis, and response to therapy.
Memorial Hospital Research Laboratories
Physician-scientist Tari King studies the molecular genetics of high-risk breast lesions and the transition from in situ to invasive breast carcinoma.
Human Oncology & Pathogenesis Program
Molecular pathologist Marc Ladanyi studies the molecular pathogenesis of sarcomas, lung cancer, and mesothelioma.
Human Oncology & Pathogenesis Program
Physician-scientist Ross Levine focuses on the investigation of genetic basis of hematopoietic malignancies.
Chair, Cancer Biology & Genetics Program, SKI
Cancer Biology & Genetics Program
Cancer Biology & Genetics Program Chair Joan Massagué studies the control of stem cell growth and phenotype in tumor progression, metastasis, and response to therapy.
Cancer Biology & Genetics Program
Cancer biologist Christine Mayr focuses on gene regulation and definition of the end of an mRNA or a transcription unit.
Human Oncology & Pathogenesis Program
Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.
Human Oncology & Pathogenesis Program
Physician-scientist Christopher Park focuses on the identification and characterization of molecular pathways that regulate normal and malignant stem cells in the hematopoietic system.
Human Oncology & Pathogenesis Program
Physician-scientist Jorge Reis-Filho focuses on the development of a predictive molecular classification for rare types of breast cancer and characterization of intratumor genetic heterogeneity in breast cancers.
Molecular Pharmacology & Chemistry Program
Pharmacologist Neal Rosen focuses on understanding biochemical mechanisms underlying phenotypes caused by tyrosine kinase activation in epithelial tumors and developing new therapeutic strategies.
Chair, Human Oncology and Pathogenesis Program
Human Oncology & Pathogenesis Program
Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.
Memorial Hospital Research Laboratories
Physician-scientist Bhuvanesh Singh focuses on delineating the role of ubiquitination in cancer pathogenesis.
Human Oncology & Pathogenesis Program
Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.
Memorial Hospital Research Laboratories
Physician-scientist Laura Tang studies the molecular pathogenesis of cell transformation in neuroendocrine neoplasms of the gastrointestinal tract and pancreas and adenocarcinomas of the stomach and gastrointestinal junction.
Memorial Hospital Research Laboratories
Physician-scientist Martin Weiser investigates the mechanisms underlying tumor spread and metastasis and how these mechanisms could be targeted.
Cancer Biology & Genetics Program
Cancer biologist Hans-Guido Wendel focuses on modeling the genetics of tumor initiation, progression, and treatment response in vivo.
